These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 12138794)
1. [Corticosteroids in the treatment of secondary antiphospholipid syndrome]. Reshetniak TM; Aleksandrova EN; Alekberova ZS; Mach ES; Nasonov EL Klin Med (Mosk); 2002; 80(6):17-21. PubMed ID: 12138794 [TBL] [Abstract][Full Text] [Related]
2. [Antiphospholipid syndrome and stroke]. Kitagawa Y Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744 [TBL] [Abstract][Full Text] [Related]
3. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome]. Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784 [TBL] [Abstract][Full Text] [Related]
4. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952 [TBL] [Abstract][Full Text] [Related]
6. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations. Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963 [TBL] [Abstract][Full Text] [Related]
16. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J; Alarcón-Segovia D J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848 [TBL] [Abstract][Full Text] [Related]
17. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity]. Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus. Sahin M; Duzgun N; Tunc SE; Tutkak H Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958 [TBL] [Abstract][Full Text] [Related]
19. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome]. Reshetniak TM; Shirokova IE; Lisitskaia TL Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359 [TBL] [Abstract][Full Text] [Related]
20. [Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up]. Reshetniak TM; Alekberova ZS; Kotel'nikova GP; Aleksandrova EN; Mach ES; Radenska-Lopovok SG; Kalashnikova LA; Nasonova VA Ter Arkh; 2003; 75(5):46-51. PubMed ID: 12847898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]